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1. Introduction 
Epidermal growth factor (EGF) is a potent mito- 
gen for a variety of cell types [l] including Swiss 3T3 
[2] and Balb/c 3T3 [3-S] fibroblast cell lines. 
Recent experiments [3-51 have shown that conflu- 
ent Balb/c 3T3 cells, which are arrested early in the 
G1 portion of the cell cycle (Go), have an increased 
number of EGF receptors relative to sparse growing 
cells. Addition of a plasma membrane-enriched frac- 
tion derived from confluent Swiss 3T3 cells to sparse- 
growing 3T3 cells arrests 50% of the cell population 
in Go during each cell cycle [6]. We show here that 
sparse cells arrested in Go by the addition of plasma 
membranes, or by culture in the absence of platelet- 
derived growth factor (PDGF), exhibit an increased 
binding of EGF relative to sparse, growing cells. We 
conclude that arrest in Go results in an up-regulation 
of the EGF receptor in Swiss 3T3 cells and that this 
effect is independent of the agent used to arrest cells 
in Go. 
2. Materials and methods 
Published procedures were used for the growth of 
3T3 cells and for the preparation of plasma mem- 
brane-enriched fractions from these cells [7,8]. NR-6 
cells are a variant of 3T3 cells which lack the receptor 
for EGF [9]. The binding of 1251-labeled EGF to cells 
was done as in [ 81; the level of non-specific binding 
was determined by the addition of non-radioactive 
EGF at 5 pg/nl. The level of non-specific binding is 
approximately the same per tissue culture dish for 
both sparse and confluent cultures, therefore the non- 
specific binding represents a greater fraction of the 
total binding for sparse cultures than for confluent 
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cultures. All binding experiments were done in tripli- 
cate, and the correction for non-specific binding is 
indicated in each case. 
Purified platelet derived growth factor (PDGF) 
[ 101 was prepared by an unpublished procedure and 
was purified -20 OOO-fold from a crude platelet 
extract (T. D. et al., in preparation). 
3. Results and discussion 
Upon EGF binding to the appropriate cell surface 
receptor [ 1 l-l 41 the EGF receptors rapidly patch 
[7,8], become internalized via coated pits [9-131, 
and are degraded within the lysosomes [ 13-151. It is 
not yet clear whether any steps of the above path- 
way, other than binding, is required for EGF to elicit 
a mitogenic response [ 16-211. The internalization 
process does, however, lead to a reduction of EGF 
receptors on the cell surface, a process which had 
been termed down-regulation [ 1,2]. The receptors for 
various peptide hormones [22,23], particularly fibro- 
blast growth factor (FGF) [24], platelet-derived 
growth factor [lo], and EGF, are co-regulated; i.e., 
addition of one hormone can either down-regulate or 
up-regulate the receptors for the other two hormones. 
Thus, the regulation of the EGF receptors on the cell 
surface appears to be complex. To determine what 
effect the position in the cell cycle has on the binding 
of EGF to the cell surface we measured the binding 
of EGF to 3T3 cells in 4 stages of growth; exponen- 
tial, density-arrested cells, membrane-arrested sparse 
cells, and mitogen-depleted (which leads to Go arrest) 
sparse cells. Addition of membranes to cells results in 
arrest of cells in Go without restricting the access of 
EGF to the cell surface [ 81. The data are represented 
in tables l-3. 
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The binding of EGF to cells in tissue culture is 
rapidly followed by internalization of the bound 
EGF. In Balb/c 3T3 cells 50% of the cell-associated 
hormone was shown to be internal after 10 min incu- 
bation at 23°C [25]. Using the same method we have 
found for confluent Swiss 3T3 cells that 90% of the 
cell-associated EGF is internal after 10 min incuba- 
tion at 37°C; by contrast, <lo% of the cell-associated 
hormone is internal after 60 min incubation at 4’C. 
Thus, we carried out binding assays both at 37°C 
and 4’ C. 
Addition of membranes to 3T3 cells arrests growth 
by a mechanism which resembles that observed at 
high cell density [6,7]. The data in tables 1 and 2 
show that either at high cell density or after addition 
of membranes, the apparent number of EGF recep- 
tors is increased relative to sparse growing cells. The 
data in table 1 were obtained at 4’C and are a mea- 
sure of the number of receptors exposed on the cell 
surface, while the data at 37°C represent a combina- 
tion of cell surface receptors and internalized hor- 
mone. The membrane preparation used in these 
experiments was derived from NR-6 cells, a variant 
obtained from 3T3 cells which lacks the EGF recep- 
tor [9], thus cell-associated membranes do not con- 
Table 1 
Binding of ‘?-labeled EGF to Swiss 3T3 cells at 4°C 
Cells 1251-labeled EGF bound 
(molecules/cell) 
(%) 
sparse, growing 34 400 100 
Sparse, + membranes 68 310 198 
Dense, arrested 68 840 197 
Sparse cells were plated at 2.4 x lo3 cells/35 mm dish 
(2 ml/dish); dense cells at 8 X IO4 cells/35 mm dish in 
Dulbecco’s modified Eagle’s medium (DME) 10% calf serum. 
At 24 h after plating alI dishes were fed with DME/S% calf 
serum. After an additional 24 h at 37°C membranes, from 
NR-6 cells, were added to some dishes (11.75 phosphodies- 
terase units/d~sh, 1.5 ml/dish, in DME/S% calf serum), while 
the other dishes received 1.5 ml DME/5% calf serum. At 48 h 
after membrane addition EGF binding was determined as 
described previously utilizing ‘zSI-labeled EGF at 25 ng/ml 
with spec. act. 96.8 &i/pg. The binding was at 4°C for 60 ‘min. 
The non-specific binding was 50% for sparse cultures, 10% 
for dense cultures. Ceil numbers were 53 700 for control 
cells, 30 150 for membrane-treated cells, and 330 000 for 
dense cells. Rates of [‘Hjthymidine incorporation into DNA 
were also determined [8] and they were, relative to the 
SPaM?g~Owing control, 47% for membrane treated cells and 
15% for the dense cells. This experiment was repeated 3 times 
with similar results 
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Table 2 
Binding of ‘2SI-Iabeled EGF to Swiss 3T3 cells at 37’C 
Cells *2S1-labeled EGF bound 
(molecules/ce~) 
(%) 
Sparse 
Sparse, + membranes 
Dense, arrested 
- 
148 400 100 
233 800 158 
312 100 210 
Sparse celIs were plated at 4 X 10” cells/35 mm dish (2 ml/ 
dish) and dense cells at 6 X lo4 cells/dish in DME/S% calf 
serum. After 48 h NR-6 membranes were added to some 
dishes at 20 PDE/dish, 1.2 ml/dish. All other dishes were fed 
with DME/S% calf serum, 1.2 ml/dish. Two days after mem- 
brane addition EGF binding was determined using ‘251-labeled 
EGF at 40 ng/ml, 56.1 #Zi/Gg. Non-specific binding was 40% 
for the sparse cultures, 7% for the dense. Cell numbers at the 
time of assay were 36 400 for control, 23 000 for membrane- 
treated and 190 000 for dense cultures. Membrane treated 
cultures had a DNA synthesis rate 30% that of control; dense 
cells were at 20% of control. This experiment was repeated 
6 times with essentially similar results 
tribute to the observed binding of EGF. We have con- 
sidered the possibility that the difference in surface 
exposure of the EGF receptor in confluent and sparse 
cells is ~rtifactual and could be due to carry-over 
into the assay of serum components which have 
bound to the EGF receptor, and that a higher con- 
centration of these components are present over 
sparse growing cells as compared to confluent cells. 
We have measured binding of EGF to sparse and con- 
fluent cells in the presence of 1% serum, and find at 
most a 10% reduction in binding for both sparse and 
confluent cells (not shown). 
The data in tables i -3 have been obtained at satu- 
rating or nearly saturating levels of EGF. If the change 
in EGF binding reflects a change in the affinity of the 
receptors for EGF, then the difference between grow- 
ing and arrested cells should be accentuated at low 
[EGF]. Accordingly, we have also carried out binding 
experiments at 5 ng EGF/ml and have observed the 
same differences in binding between arrested and 
growing cells as at higher [EGF] (table 4). Thus the 
effect of arresting cells at Go is primarily on the num- 
ber of binding sites and not their affinity for EGF, 
Arrest of cells by high cell density is accompanied 
by a number of physiolo~c~ changes of which altera- 
tions in the rate of uptake for solutes such as ammo 
acids or glucose are an example [ 261. Such changes 
could be due to either a density effect per se or a 
consequence of cell arrest at Go. Cell density affects 
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Table 3 
Binding of ‘251-labeled EGF to arrested and stimulated 
3T3 cells at 4°C 
Cells ‘2SI-labeled EGF bound 
(molecules/cell) (%) 
DNA 
synthesis 
rate (%) 
Sparse, growing 38 600 100 100 
Dense, arrested 109 800 284 14 
Sparse, starved 173 500 449 18 
+ PDGF (4 h) 142 800 370 12 
+ PDGF (16 h) 183 720 476 85 
Sparse cells were plated at 2.4 X lo3 cells/35 mm dish; cells 
to be starved were plated at 4.8 X lo3 cells/35 mm dish, and 
dense cells were plated at 8 X lo4 cells/dish (at 2 ml/dish), all 
in DME/lO% calf serum. Two days after plating some cells 
were starved by incubation in medium containing 1% plasma 
rather than serum and therefore lacking PDGF [lo]. For this 
purpose cultures were washed twice with DME followed by 
2.0 ml DME/l% calf plasma, prepared as in [8]. Control cul- 
tures received 1.5 ml fresh DME/5% calf serum. This concen- 
tration of serum gives a maximal mitogenic response for 
sparse cells. After 48 h EGF binding and rates of DNA syn- 
thesis were determined. The 1251-labeled EGF was used at 
50 ng/ml, 96.8 nCi/ng and binding done at 4°C for 60 min. 
Partially purified platelet factor (20 ng/ml) (PDGF) was 
added to some starved cells and the binding determined both 
4 h and 16 h after PDGF addition. Non-specific binding was 
between 50-60% for sparse cells, 10% for dense cells. Cell 
numbers were 34 000 for control cells, 17 000-19 000 for 
starved cells and 300 000 for dense cultures. When binding 
was measured for 30 min at 37’C control cells bound 
0.17 cpm/cell (loo%), whereas starved cells bound 0.61 cpm/ 
cell (360%). These experiments have been done twice with 
identical results 
Table 4 
Binding of ‘ZSI-labeled EGF to 3T3 cells at 5 ng EGF/ml and 
50 ng EGF/ml 
Cells ‘*51-labeled EGF bound 
5 ng/ml 50 ng/ml 
(molecules/cell) 
Sparse, growing 18 600 38 600 
Sparse + membranes 37 200 99 000 
Sparse, starved 55 800 173 000 
Dense, arrested 37 200 109 000 
The protocol for this experiment was as in table 1. Binding 
of ‘251-labeled EGF was measured at 4°C for 60 min. The 
level of non-specific binding at 5 ng EGF/ml was 25% for 
sparse cells and confluent cells 
the rate of a-aminoisobutyric acid and glucose trans- 
port in cells already arrested in Go [27]. To answer 
this question (cell density YS Go arrest) regarding the 
increase in the level of EGF receptors at confluency, 
we have measured the level of EGF receptor in sparse 
cells which were arrested in Go by incubation in 
1% calf plasma, which lacks the major mitogen for 
3T3 cells present in serum (platelet derived growth 
factor (PDGF)) [lo]. Representative data are shown 
in table 3. Arrest of cells in Go by removal of PDGF 
also results in an increased level of EGF binding to 
the cells. Thus we conclude that arrest of cells in Go, 
whether by density or by limiting concentration of a 
mitogen, is sufficient to increase the level of the EGF 
receptor. Addition of PDGF to plasma-arrested cells 
results in a synchronous reentry of the cells into the 
cell cycle. The data in table 3 show that either 4 h 
after PDGF addition or 16 h after PDGF addition the 
number of cell surface receptors for EGF remains 
high. At 4 h after EGF addition the cells are still in 
Gr and at 16 h are mostly in the S phase of the cell 
cycle scheme. At this time one observes the highest 
rate of DNA synthesis after addition of PDGF to the 
cells. Thus, down-regulation of the EGF receptor to a 
level comparable to that observed in sparse-growing 
cells is not an immediate consequence of the initia- 
tion of growth following mitogen stimulation nor 
does it reflect an obligatory event at the cell surface 
required for the initiation of cell growth. 
Increased levels of mitogen receptor at the cell sur- 
face under conditions of growth arrest can be con- 
sidered to represent a compensatory mechanism such 
that at a given concentration of hormone or mito- 
genie factor more sites per cell would be occupied; 
thus, even at sub-optimal hormone levels sufficient 
sites may be occupied to elicit a mitogenic response. 
Hormone or mitogen receptors in a number of 
instances have been shown to be down-regulated as a 
consequence of occupancy of the receptor [ 1,281. 
These observations suggest hat the level of the EGF 
receptor can also be controlled by other ligands that 
do not bind to the EGF receptor, including surface 
components from other cells (contact inhibition of 
growth) and mitogenic components present in serum. 
Relevant to this argument is the demonstration that 
binding of NR-6 membranes to 3T3 cells does not 
prevent access of EGF to the cell surface [8]. The 
opposite effect has been shown for BSC-1 cells [29]; 
as these cells reach confluence the EGF receptors on 
the cell surface decrease lo-fold. We interpret these 
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data to indicate that cell-cell contact leads to a 
down-regulation of EGF receptors in these cells; once 
the receptors are down-regulated the cells are less 
reponsive to serum factors and undergo growth arrest. 
The opposite, however, appears to be the case for 
3T3 cells; growth arrest by cell-cell contact leads to 
a compensatory mechanism of receptor up-regulation, 
which could lead to initiation of growth in response 
to sub-optimal levels of mitogens. 
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